Hospira Carpuject Recall Issued Due to Potential Leaks of Some Drug Products
Failure of the Carpuject injection seals may lead to the need for further medical treatment, the FDA warns.
Failure of the Carpuject injection seals may lead to the need for further medical treatment, the FDA warns.
Recalled Chinese syringes were not approved by the FDA, and may be prone to leaking and breaking, causing life-threatening injuries and complications
FDA never approved recent changes in manufacturers and new dimensions for the syringe sizes, which led to a massive Monoject syringe recall earlier this year
The FDA has declared a February product correction as a Class I Monoject syringe recall, following numerous reports of problems with the new syringes' dimensions.
The FDA first warned of problems with Cardinal Health Monoject syringes failing to fit drug pumps in November 2023.
About a dozen incompatibility problems with Alaris infusion pumps and Cardinal Health Monoject syringes have been reported.
Warning comes after Cardinal Health recalled more than 32 million syringes in September, because they may not fit correctly into certain pain management drug pumps.
The FDA warns that the recalled syringes could cause infections, blood loss, increased blood clot risks, embolism and death.